Compare HLT & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HLT | BSX |
|---|---|---|
| Founded | 1919 | 1979 |
| Country | United States | United States |
| Employees | N/A | 59000 |
| Industry | Hotels/Resorts | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.3B | 65.8B |
| IPO Year | 2013 | 2010 |
| Metric | HLT | BSX |
|---|---|---|
| Price | $324.97 | $44.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 15 | 22 |
| Target Price | ★ $322.13 | $93.18 |
| AVG Volume (30 Days) | 2.0M | ★ 17.2M |
| Earning Date | 04-28-2026 | 04-22-2026 |
| Dividend Yield | ★ 0.19% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | ★ 1.66 | 0.90 |
| Revenue | ★ $12,039,000,000.00 | $9,076,000,000.00 |
| Revenue This Year | $9.82 | $11.85 |
| Revenue Next Year | $8.37 | $10.16 |
| P/E Ratio | $192.88 | ★ $48.42 |
| Revenue Growth | 7.74 | ★ 12.49 |
| 52 Week Low | $253.54 | $42.20 |
| 52 Week High | $358.00 | $109.50 |
| Indicator | HLT | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 45.31 | 46.85 |
| Support Level | $308.41 | $42.23 |
| Resistance Level | $333.86 | $46.37 |
| Average True Range (ATR) | 7.09 | 1.17 |
| MACD | -0.89 | 0.29 |
| Stochastic Oscillator | 34.81 | 55.04 |
Hilton Worldwide Holdings operates 1.36 million rooms across its 27 brands, serving the premium economy through luxury segments. Hampton and Hilton are the two largest brands, representing 27% and 18%, respectively, of the company's total rooms, as of Dec. 31, 2025. Recent brands launched over the past few years include Home2, Curio, Canopy, Spark, Tru, Tempo, LivSmart, and Outset. Additionally, there is a partnership with Small Luxury Hotels of the World and acquisitions of NoMad and Graduate Hotels. Managed and franchised hotels represent the vast majority of adjusted EBITDA, predominantly from the Americas.
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.